CNBX Pharmaceuticals Inc. financial data

Symbol
CNBX on OTC
Industry
Pharmaceutical Preparations
Location
#3 Bethesda Metro Center, Suite 700, Bethesda, MD
State of incorporation
NV
Fiscal year end
August 31
Former names
Cannabics Pharmaceuticals Inc. (to 3/16/2022), American Mining Corp (to 5/1/2014), Thrust Energy Corp. (to 5/10/2011)
Latest financial report
10-Q - Q1 2025 - Apr 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.81 % -79.4%
Return On Equity 11.8 % -79.9%
Return On Assets -641 % -123%
Operating Margin -1.1K % -628%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.2M shares -86.5%
Common Stock, Shares, Outstanding 33.9M shares +988%
Entity Public Float 438K USD -75.8%
Common Stock, Value, Issued 3.39K USD +8.84%
Weighted Average Number of Shares Outstanding, Basic 32.1M shares +3.58%
Weighted Average Number of Shares Outstanding, Diluted 32.1M shares +3.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Cost of Revenue 0 USD -100%
Research and Development Expense -24.8K USD -104%
General and Administrative Expense 337K USD -49.7%
Operating Income (Loss) -306K USD +57%
Net Income (Loss) Attributable to Parent -295K USD +76%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 45.7K USD +23%
Assets, Current 50.7K USD -69.1%
Property, Plant and Equipment, Net 0 USD
Assets 50.7K USD -69.1%
Liabilities, Current 2.62M USD +3.91%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -25.1M USD -1.19%
Stockholders' Equity Attributable to Parent -2.57M USD -8.99%
Liabilities and Equity 50.7K USD -69.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.1K USD +45.6%
Net Cash Provided by (Used in) Financing Activities 30K USD +20%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 33.9M shares +988%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.08K USD +81.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 45.7K USD +23%
Deferred Tax Assets, Valuation Allowance 3.47M USD +3.86%
Depreciation 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -295K USD +74.8%
Deferred Tax Assets, Operating Loss Carryforwards 3.47M USD +3.86%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares +1900%
Additional Paid in Capital 22.5M USD +0.37%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%